Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 4Phase 2 3Phase 1 2Phase NA 1

Status

Completed 4

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cancer Pain 9Neoplasms 6Pain 4Prostatic Neoplasms 1Osteoarthritis 1Opioid-Induced Constipation 1Lymphoma, Follicular 1Inflammation 1Head and Neck Neoplasms 1Endobronchial Metastases 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Back Pain 1Agnosia 1Acute Pain 1

Interventions

Fentanyl 9Acetaminophen 5Zoledronic Acid 4Oxycodone 4Ketamine 4Bupivacaine 4Sufentanil 3Hydromorphone 3Diclofenac 3Ropivacaine 2Pregabalin 2Morphine 2Ketorolac 2Ibuprofen 2Ibandronic Acid 2Esketamine 2Epinephrine 2naloxegol 1chloroprocaine 1acetaminophen, aspirin, caffeine drug combination 1Varenicline 1Uterine Artery Embolization 1Ultracet 1Therapeutics 1Propofol 1Pamidronate 1Oxygen 1Nitrous Oxide 1Naproxen 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Pain × Oxycodone × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

NCT03176121 2020-03-18

STOP Pain

Taiwan Mundipharma Pharmaceuticals Ltd.

Phase 4 Completed
73 enrolled

Cancer Pain, Neoplasms, Pain

NCT03176199 2020-03-18

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

Taiwan Mundipharma Pharmaceuticals Ltd.

Phase 4 Completed
30 enrolled

Cancer Pain, Neoplasms, Pain

NCT00378937 2013-08-02

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

National Cancer Institute (NCI)

Phase 4 Completed
30 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡